confident

Automate Your Business with the Power of CPR+ BI

Whether you are in HME/DME, home infusion or specialty pharmacy, CPR+ can help you achieve higher revenues, greater efficiency and better compliance with ever-changing regulations. See how our latest business intelligence suite, CPR+ BI, can cut reporting time in half and customize your data to satisfy payer, manufacturer, and accreditation requirements.

Bring your data into focus with custom reporting

CPR+ business intelligence provides a complete set of data analysis tools that allow you to see even the most microscopic details of your data and then bring them into focus. Using live data in the system, CPR+ eliminates the need to rework weekly reports in spreadsheets and instead delivers the data you need, when you need it.  For more information about CPR+ business intelligence, please call Jon Love, of Rock-Pond Solutions, 501-232-4355, or email info@rock-pond.com.

acloselook_data
shutterstock_531740502

CPR+ Product Support

CPR+ customers will continue to receive regulatory updates and other enhancements. For CPR+ product support, please call 877-277-4876 or email cpr-support@mediware.com.

Take your Business into the Future

The post-acute healthcare industry is changing and evolving, and so is Mediware. After working with our customers to understand their core needs, followed by years of technology development, we designed CareTend. Our integrated solution streamlines patient management in a way that you won’t find anywhere else in the market. CareTend is a complete software suite that manages HME, home infusion, and specialty pharmacy business needs so that you can spend less time managing technology and more time serving patients. Learn more about CareTend software, and how it can take your business to the next level.

  • Open SQL architecture for improved data exploration
  • Hosted and on-premise deployment options
  • Advanced reporting and analytic functionality
  • Secure data transition and migration road map from CPR+ to CareTend
2016 into the future